CLEVELAND - A new predictor of cornea transplant success has been identified by the Cornea Donor Study (CDS) Investigator Group. New analysis of data from the 2008 Specular Microscopy Ancillary Study ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal ...
FDA Says No to Lifitegrast for Dry Eye, Requests More Data In a complete response letter, the FDA asked for another study on the experimental ophthalmic solution for dry eye and further information ...
Corneal disease is the primary cause of visual loss in allergic eye disease. It occurs almost exclusively in vernal keratoconjunctivitis and atopic keratoconjunctivitis. It is characterized by ...
Please provide your email address to receive an email when new articles are posted on . Neuropathy and inflammation work together to drive common manifestations of corneal disease. Early intervention ...
University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that uses naturally occurring eye bacteria to support corneal wound healing. The ...
A study of patients undergoing corneal transplants indicates that subtle differences between men and women may lead to poorer outcomes for a woman who has received a cornea from a male donor. The ...
A new study published in the journal of Contact Lens & Anterior Eye showed that the risk of keratoconus and corneal erosion is considerably higher in individuals with allergic ...
Her five-year, $1.8 million R01 grant titled “Corneal Endothelium – Extracellular Matrix Interactions” is from the National Eye Institute. The cornea is a clear dome on the front of the eye that helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results